Maxim Group’s 2024 Healthcare Virtual Summit
Logotype for Milestone Scientific Inc

Milestone Scientific (MLSS) Maxim Group’s 2024 Healthcare Virtual Summit summary

Event summary combining transcript, slides, and related documents.

Logotype for Milestone Scientific Inc

Maxim Group’s 2024 Healthcare Virtual Summit summary

19 Jan, 2026

Key business developments

  • Secured Medicare reimbursement pricing for technology, enabling private practitioners to receive $325 per procedure in addition to the primary rate.

  • Initiated commercialization through a partnership with Axial Biologics, leveraging their relationships in New Jersey, Florida, and Texas.

  • Launched pilot programs in clinics, focusing on building a baseline of committed clinics with minimum annual purchase volumes to establish 2025 revenue.

  • Expanded sales force with 27 additional representatives via Axial Biologics and added 1099 salespeople.

  • Continued strong performance in the dental business, with $9M+ in sales and $2.2M net profit last year.

Market opportunity and strategy

  • Targeting a $2B total addressable market in pain management, with 9M procedures annually, and focusing on Medicare patients in key states.

  • Pricing strategy set to minimize upfront costs for clinicians, offering devices at $1,000 and consumables at $200–$250 per procedure.

  • Building a recurring revenue model by requiring minimum annual purchase volumes from clinics.

  • International expansion efforts ongoing, with Brazil identified as a key future market.

  • Seeking partnerships with smaller, focused distributors to accelerate adoption and avoid competition for attention.

Technology and clinical impact

  • CompuFlo system offers objective, computer-controlled needle placement, reducing training time for clinicians from two years to two procedures.

  • Clinical studies show over 99.9% first-attempt success rate, compared to 17% false positives with traditional methods.

  • Technology reduces risk of complications such as cerebrospinal fluid leakage, migraines, paralysis, and mortality, especially in thoracic and cervical procedures.

  • Demonstrated $400–$504 average savings per patient stay and significant reduction in litigation risk.

  • System improves efficiency, safety, and predictability in both labor/delivery and pain management settings.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more